Collectively, our study demonstrated that inhibition of Rac1 activation protects against arrhythmogenesis during myocardial I/R, and may represent a new paradigm for the treatment of cardiac arrhythmia in ischemic heart disease. This evidence concerns the gene RAC1 and chronic obstructive pulmonary disease.